0001209191-18-041039.txt : 20180703
0001209191-18-041039.hdr.sgml : 20180703
20180703162037
ACCESSION NUMBER: 0001209191-18-041039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180629
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arbuckle Stuart A
CENTRAL INDEX KEY: 0001557290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18937580
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-29
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001557290
Arbuckle Stuart A
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP\Chief Commercial Officer
Common Stock
2018-06-29
4
M
0
2155
91.05
A
48907
D
Common Stock
2018-06-29
4
M
0
1553
86.52
A
50460
D
Common Stock
2018-06-29
4
S
0
3708
169.00
D
46752
D
Common Stock
140
I
401(k)
Stock Option (Right to Buy)
91.05
2018-06-29
4
M
0
2155
0.00
D
2026-02-01
Common Stock
2155
15086
D
Stock Option (Right to Buy)
86.52
2018-06-29
4
M
0
1553
0.00
D
2027-02-02
Common Stock
1553
17086
D
Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 2/2/2016.
The option vests in 16 quarterly installments from 2/3/2017.
/s/ Stephen Migausky, Attorney-in-Fact
2018-07-03